Neuropathic Pain Treatment Market By Treatment Type (Medications {Anticonvulsants, Antidepressants, Opioids, Local Anesthetics, Topical Agents} Therapies {Nerve Stimulation, Spinal Cord Stimulation, Transcutaneous Electrical Nerve Stimulation, Radiofrequency Ablation, and Others}), By Indication (Pain Management, Neurological Disorders, Orthopaedic and Musculoskeletal Disorders, Diabetes Management, and Others), By Route of Administration ( Oral, Topical, Injectable), By End User (Hospitals, Pain Clinics, Home Care Settings, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Jan 2025 | Report ID: MI1748 | 220 Pages
Report Coverage:
By Treatment Type
- Medications
- Anticonvulsants
- Antidepressants
- Opioids
- Local Anesthetics
- Topical Agents
- Therapies
- Nerve Stimulation
- Spinal Cord Stimulation
- TENS (Transcutaneous Electrical Nerve Stimulation)
- Radiofrequency Ablation
- Other
By Indication
- Pain Management
- Neurological Disorders
- Orthopaedic and Musculoskeletal Disorders
- Diabetes Management
- Other
By Route of Administration
- Oral
- Topical
- Injectable
End User
- Hospitals
- Pain Clinics
- Home Care Settings
- Others
By Region
North America
- The U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East & Africa
List of Companies:
- Pfizer Inc.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Grünenthal GmbH
- Mallinckrodt Pharmaceuticals
- GlaxoSmithKline PLC
- Eli Lilly and Company
- Abbott Laboratories
- Sanofi S.A.
- Johnson & Johnson Private Limited
- Sun Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Cipla Inc.
- Biogen Inc.
- Boston Scientific Corporation
- Medtronic Inc.
- Stryker Corporation
- Bristol-Myers Squibb Company
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.